Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma

Journal of the American Academy of Dermatology

Volumn 51, Issue 3, 2004, Pages 399-405

  Wang, Timothy S ^a   Johnson, Timothy M ^a   Cascade, Phillip N ^a   Redman, Bruce G ^a   Sondak, Vernon K ^a   Schwartz, Jennifer L ^a  

^a Int Medicine Hematology/Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CORRELATION ANALYSIS; DATA ANALYSIS; DATA BASE; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; OBSERVER VARIATION; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 4444364185     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.02.017     Document Type: Article

References (55)

1. Balch C.M., Soong S., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 19:2001;3622-3634
2. Balch C.M., Buzaid A.C., Soong S., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 19:2001;3635-3648
3. Terhune M.H., Swanson N., Johnson T.M. Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol. 134:1998;569-572
4. Khansur T., Sanders J., Das S.K. Evaluation of staging workup in malignant melanoma. Arch Surg. 124:1989;847-849
5. Ardizzoni A., Grimaldi A., Repetto L., Bruzzone M., Sertoli M.R., Rosso R. Stage I-II melanoma: the value of metastatic work-up. Oncology. 44:1987;87-89
6. Buzaid A.C., Tinoco L., Ross M.I., Legha S.S., Benjamin R.S. Role of computed tomography in the staging of patients with local-regional metastases of melanoma. J Clin Oncol. 13:1995;2104-2108
7. Hofmann U., Szedlak M., Rittgen W., Jung E.G., Schadendorf D. Primary staging and follow-up in melanoma patients - monocenter evaluation of methods, costs and patient survival. Br J Cancer. 87:2002;151-157
8. Iscoe N., Kersey P., Gapski J., Osoba D., From L., DeBoer G., et al. Predictive value of staging investigations in patients with clinical stage I malignant melanoma. Plast Reconstr Surg. 80:1987;233-239
9. Kersey P.A., Iscoe N.A., Gapski J.A., Osoba D., From L., DeBoer G., et al. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma. Br J Surg. 72:1985;614-617
10. Buzaid A.C., Sandler A.B., Mani S., Curtis A.M., Poo W.J., Bolognia J.L., et al. Role of computed tomography in the staging of primary melanoma. J Clin Oncol. 11:1993;638-643
11. Zartman G.M., Thomas M.R., Robinson W.A. Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol. 35:1987;163-164
12. Huang C.L., Provost N., Marghoob A.A., Kopf A.W., Levin L., Bart R.S. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma. J Am Acad Dermatol. 39:1998;451-463
13. Garbe C., Paul A., Kohler-Spath H., Ellwanger U., Stroebel W., Schwarz M., et al. Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol. 21:2003;520-529
14. National Comprehensive Cancer Network. Clinical practice guidelines in oncology - v.1.2003. Melanoma. Available at: www.nccn.org/physician_gls/ f_guidelines.html. Accessed November 7, 2003.
15. National Institutes of Health. Diagnosis and treatment of early melanoma. NIH Consensus Statement. 10:1992;1-26
16. Tarnoff M., Moncure M., Jones F., Ross S., Goodman M. The value of routine posttracheostomy chest radiography. Chest. 113:1998;1647-1649
17. Tyroch A.H., Kaups K., Lorenzo M., Schreiber M., Solis D. Routine chest radiograph is not indicated after open tracheostomy: a multicenter perspective. Am Surg. 68:2002;80-82
18. Morice P., Levy-Piedbois C., Ajaj S., Pautier P., Haie-Meder C., Lhomme C., et al. Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer. Eur J Cancer. 37:2001;985-990
19. Myers R.E., Johnston M., Pritchard K., Levine M., Oliver T. Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Baseline staging tests in primary breast cancer: a practice guideline. CMAJ. 164:2001;1439-1444
20. Ranparia D.J., Hart L., Assimos D.G. Utility of chest radiography and cystoscopy in the evaluation of patients with localized prostate cancer. Urology. 48:1996;72-74
21. Krivopal M., Shlobin O.A., Schwartzstein R.M. Utility of daily routine portable chest radiographs in mechanically ventilated patients in the medical ICU. Chest. 123:2003;1607-1614
22. Petersen W.G., Zimmerman R. Limited utility of chest radiograph after thoracentesis. Chest. 117:2000;1038-1042
23. Pacharn P., Heller D.N., Kammen B.F., Bryce T.J., Reddy M.V., Bailey R.A., et al. Are chest radiographs routinely necessary following thoracostomy tube removal? Pediatr Radiol. 32:2002;138-142
24. Amshel C.E., Palesty J.A., Dudrick S.J. Are chest X-rays mandatory following central venous recatheterization over a wire? Am Surg. 64:1998;499-501
25. Archer C., Levy A.R., McGregor M. Value of routine preoperative chest x-rays: a meta-analysis. Can J Anaesth. 40:1993;1022-1027
26. Barak M., Markovits R., Guralnik L., Rozenberg B., Ziser A. The utility of routine postoperative chest radiography in the post anesthesia care unit. J Clin Anesth. 9:1997;351-354
27. Sagar G., Riley P., Vohrah A. Is admission chest radiography of any clinical value in acute stroke patients? Clin Radiol. 51:1996;499-502
28. Alsumait B.M., Alhumood S.A., Ivanova T., Mores M., Edeia M. A prospective evaluation of preoperative screening laboratory tests in general surgery patients. Med Princ Pract. 11:2002;42-45
29. McMasters K.M., Reintgen D.S., Ross M.I., Gershenwald J.E., Edwards M.J., Sober A., et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol. 19:2001;2851-2855
30. McMasters K.M., Chao C., Wong S.L., Wrightson W.R., Ross M.I., Reintgen D.S., et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 137:2002;543-547
31. Uren R.F., Howman-Giles R., Thompson J.F., McCarthy W.H., Quinn M.J., Roberts J.M., et al. Interval nodes: the forgotten sentinel nodes in patients with melanoma. Arch Surg. 135:2000;1168-1172
32. Thompson J.F., Uren R.F., Shaw H.M., McCarthy W.H., Quinn M.J., O'Brien C.J., et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg. 189:1999;195-204
33. Sober A.J., Chuang T.Y., Duvic M., Farmer E.R., Grichnik J.M., Halpern A.C., et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 45:2001;579-586
34. Veronesi U., Cascinelli N., Adamus J., Balch C., Bandiera D., Barchuk A., et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 318:1988;1159-1162
35. Veronesi U., Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg. 126:1991;438-441
36. Balch C.M., Soong S., Smith T., Ross M.I., Urist M.M., Karakousis C.P., et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 8:2001;101-108
37. Heaton K.M., Sussman J.J., Gershenwald J.E., Lee J.E., Reintgen D.S., Mansfield P.F., et al. Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Ann Surg Oncol. 5:1998;322-328
38. Cascinelli N., Belli F., Santinami M., Fait V., Testori A., Ruka W., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol. 7:2000;469-474
39. Gross E.A. Initial evaluation of melanoma. Don't stop getting that chest x-ray... yet. [letter; comment] Arch Dermatol. 134:1998;623-624
40. Loprinzi C.L., Hayes D., Smith T. The art of oncology: when the tumor is not the target; Doc, shouldn't we be getting some tests? J Clin Oncol. 18:2000;2345-2348
41. Albert V.A., Koh H.K., Geller A.C., Miller D.R., Prout M.N., Lew R.A. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol. 23:1990;308-310
42. Provost N., Marghoob A.A., Kopf A.W., DeDavid M., Wasti Q., Bart R.S. Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians. J Am Acad Dermatol. 36:1997;711-720
43. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26
44. Johnson T.M., Bradford C.R., Gruber S.B., Sondak V.K., Schwartz J.L. Staging work-up, sentinel node biopsy and follow-up tests for melanoma: update of current concepts. Arch Dermatol. 140:2004;107-113
45. Meyer J.E., Stolbach L. Pretreatment radiographic evaluation of patients with malignant melanoma. Cancer. 42:1978;125-126
46. Johnson T.M., Fader D.J., Chang A.E., Yahanda A., Smith J.W. 2nd, Hamlet K.R., et al. Computed tomography in staging of patients with melanoma metastatic to the regional lymph nodes. Ann Surg Oncol. 4:1997;396-402
47. Weiss M., Loprinzi C.L., Creagan E.T., Dalton R.J., Novotny P., O'Fallon J.R. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 274:1995;1703-1705
48. Mooney M.M., Kulas M., McKinley B., Michalek A.M., Kraybill W.G. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma. Ann Surg Oncol. 5:1998;54-63
49. Basseres N., Grob J.J., Richard M.A., Thirion X., Zarour H., Noe C., et al. Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France. Dermatology. 191:1995;199-203
50. Blum A., Schlagenhauff B., Stroebel W., Breuninger H., Rassner G., Garbe C. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: results of a prospective study of 1288 patients. Cancer. 88:2000;2534-2539
51. Meyers M.L., Balch C.M. Diagnosis and treatment of metastatic melanoma. Balch C.M., Houghton A.N., Sober A.J., Soong S. Cutaneous Melanoma. (3rd edition) :1998;325-372 Quality Medical Publishing, Inc., St Louis
52. Johnson T.M., Yahanda A.M., Chang A.E., Fader D.J., Sondak V.K. Advances in melanoma therapy. J Am Acad Dermatol. 38:1998;731-741
53. Rose D.M., Essner R., Hughes T.M., Tang P.C., Bilchik A., Wanek L.A., et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg. 136:2001;950-955
54. Ollila D.W., Stern S.L., Morton D.L. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol. 69:1998;206-211
55. Leo F., Cagini L., Rocmans P., Cappello M., Geel A.N., Maggi G., et al. Lung metastases from melanoma: when is surgical treatment warranted? Br J Cancer. 83:2000;569-572